Timothy Eugene Sullivan
Chief Financial Officer · 5 filings · Latest: May 14, 2026
Apellis Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APLS | Timothy Eugene Sullivan | Chief Financial Officer | Jan 22, 2026 | Sale | $21.77 | 10,287 | $223.9K | 93,901 | |
APLS | Sullivan Timothy Eugene | — | Jan 22, 2026 | Proposed Sale | $21.77 | 10,287 | $223.9K | — | |
APLS | Timothy Eugene Sullivan | Chief Financial Officer | Jan 20, 2026 | Sale | $19.79 | 2,892 | $57.2K | 104,188 | |
APLS | Sullivan Timothy Eugene | — | Jan 20, 2026 | Proposed Sale | $19.79 | 2,892 | $57.2K | — | |
APLS | Sullivan Timothy Eugene | — | Jan 13, 2026 | Proposed Sale | $22.19 | 3,856 | $85.6K | — | |
APLS | Sullivan Timothy Eugene | — | Oct 21, 2025 | Proposed Sale | $28.03 | 10,000 | $280.3K | — | |
APLS | Timothy E Sullivan Irrevocable Trust of 2023 DTD 03/30/2023 | — | Sep 8, 2025 | Proposed Sale | $28.00 | 10,000 | $280.0K | — | |
APLS | Sullivan Timothy Eugene | — | Sep 8, 2025 | Proposed Sale | $27.86 | 32,729 | $911.8K | — | |
APLS | Sullivan Timothy Eugene | — | Jan 29, 2025 | Proposed Sale | $29.52 | 546 | $16.1K | — | |
APLS | Sullivan Timothy Eugene | — | Jan 22, 2025 | Proposed Sale | $30.43 | 3,088 | $94.0K | — | |
APLS | Sullivan Timothy Eugene | — | Jan 17, 2025 | Proposed Sale | $29.96 | 1,730 | $51.8K | — | |
APLS | Sullivan Timothy Eugene | — | Jan 13, 2025 | Proposed Sale | $28.70 | 2,209 | $63.4K | — |